3 Stocks Breaking Out Right Now

07.03.25 17:55 Uhr

Werte in diesem Artikel
Aktien

13,40 EUR -0,20 EUR -1,47%

(0:30) - Finding Strong Stocks Amid A Stock Market Sell-Off(5:00) - Top Stock Picks To Keep On Your Watchlist Right Now(23:10) - Episode Roundup: BRKB, AON, ABBV            Poodcast@Zacks.com Welcome to Episode #436 of the Zacks Market Edge Podcast.Every week, host and Zacks stock strategist, Tracey Ryniec, will be joined by guests to discuss the hottest investing topics in stocks, bonds, and ETFs and how it impacts your life.This week, Tracey is going solo to look at stocks that are bucking the bearish trend on Wall Street. Instead, these three stocks are touching new all-time highs.They aren’t technology stocks, although one is in the rare group of trillion-dollar market cap companies along with the Magnificent 7 stocks.These are mostly “old economy” type companies in paints, railroads, energy, insurance, and big cap pharmaceuticals.3 Stocks Breaking Out Right Now1. Berkshire Hathaway (BRK.B)Berkshire Hathaway is involved in just about every type of business you can think of. It also has a large equity portfolio which owns some Mag 7 stocks like Amazon and Apple.Investors are hiding out in Berkshire Hathaway in 2025. Shares of Berkshire Hathaway are up 9.3% year-to-date and is in the green over the last month. The stock has busted out to new all-time highs this year.Berkshire Hathaway is not a cheap stock. It has a forward price-to-earnings (P/E) ratio of 24.5. A P/E under 15 is often considered a “value” stock.Even Warren Buffett is staying out of it as Berkshire Hathaway did not repurchase any shares with its cash last quarter.Is Berkshire Hathaway the ultimate defensive play in 2025?2. Aon plc (AON)Aon is a global professional services firm with commercial risk, reinsurance, and wealth solutions, among others. Earnings are expected to rise 10.3% in 2025.Shares of Aon have been hitting new all-time highs the past 2 weeks even as the tariffs have roiled the markets. Aon is up 11.8% year-to-date.Aon is trading with a forward P/E of 23.5. It also pays a dividend, yielding 0.7%.Should Aon be on your short list for 2025?3. AbbVie Inc. (ABBV)AbbVie is a big cap pharmaceutical company which had one of the blockbuster drugs, Humira, over the last decade. But Humira recently went off patent. AbbVie has been trying to replace the revenue. Has it succeeded?AbbVie has Skyrizi, Rinvoq, and Botox in its product line up now. Earnings are expected to rise 21.6% in 2025.Shares of AbbVie were hitting new highs this week while the tariffs were rocking the stock market. AbbVie is up 18% year-to-date. Yet it’s still attractively priced. AbbVie has a forward P/E of 17.2.AbbVie also pays a dividend, yielding 3.1%.Should investors hide out in AbbVie in 2025?What Else Do You Need to Know About Stocks Breaking Out? Tune into this week’s podcast to find out.[In full disclosure, Tracey owns shares of ABBV in her personal portfolio and in Zacks Value Investor and shares of AON in the Insider Trader portfolio.] Just Released: Zacks Top 10 Stocks for 2025Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Berkshire Hathaway Inc. (BRK.B): Free Stock Analysis Report Aon plc (AON): Free Stock Analysis Report AbbVie Inc. (ABBV): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf NOW

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf NOW

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu NOW Inc When Issued

Wer­bung

Analysen zu NOW Inc When Issued

DatumRatingAnalyst
05.08.2019NOW Market PerformCowen and Company, LLC
03.08.2018NOW BuyStifel, Nicolaus & Co., Inc.
03.08.2018NOW Market PerformCowen and Company, LLC
03.05.2018NOW Market PerformCowen and Company, LLC
15.02.2018NOW BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
03.08.2018NOW BuyStifel, Nicolaus & Co., Inc.
15.02.2018NOW BuyStifel, Nicolaus & Co., Inc.
16.01.2018NOW BuyStifel, Nicolaus & Co., Inc.
06.06.2017NOW BuyStifel, Nicolaus & Co., Inc.
04.05.2017NOW BuySeaport Global Securities
DatumRatingAnalyst
05.08.2019NOW Market PerformCowen and Company, LLC
03.08.2018NOW Market PerformCowen and Company, LLC
03.05.2018NOW Market PerformCowen and Company, LLC
15.02.2018NOW Market PerformCowen and Company, LLC
02.11.2017NOW Market PerformCowen and Company, LLC
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für NOW Inc When Issued nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen